A Review on Eye Diseases Induced by Blue Light: Pathology, Model, Active Ingredients and Mechanisms

Overview

Journal Front Pharmacol

Date 2025 Feb 7

PMID 39917620

Authors

Yuan Yan

Yiyao Wu

Yu Zhao

Yaguang Yang

Guangtao An

Zhidong Liu

Dongli Qi

Affiliations

Soon will be listed here.

Abstract

Blue light induced eye damage (BLED) belongs to modern diseases. It is an ophthalmic disease caused by prolonged exposure to electronic devices or screens containing a large amount of high-energy short waves (blue light). Specific symptoms include dryness and discomfort in the eyes, blurred vision, headache, insomnia, and in severe cases, it may also cause various eye diseases such as cataracts and glaucoma. At present, the development of health products and drugs for eye blue light injury faces many difficulties. Therefore, further exploration and research are needed on the pathogenesis, pathophysiology, and pharmacological mechanisms of blue light injury. Natural medicine ingredients and preparations have unique advantages in targeting eye blue light injury fatigue products due to their multi-component synergistic effects, overall regulation, and mild and safe characteristics. Starting from the disease-related mechanisms and pathophysiological characteristics of eye blue light injury, this article elucidates the pharmacological mechanisms of various drugs for treating eye blue light injury. At the same time, it reviews the research on cultured cell and animal model conditions for blue light injury eyes, in order to provide reference for subsequent blue light injury modeling experiments. And explore future research directions to provide new ideas and methods for the prevention and treatment of BLED.

References

Li H, Zhang M, Wang D, Dong G, Chen Z, Li S . Blue Light from Cell Phones Can Cause Chronic Retinal Light Injury: The Evidence from a Clinical Observational Study and a SD Rat Model. Biomed Res Int. 2021; 2021:3236892. PMC: 8147535. DOI: 10.1155/2021/3236892. View

Nakanishi T, Shimazawa M, Sugitani S, Kudo T, Imai S, Inokuchi Y . Role of endoplasmic reticulum stress in light-induced photoreceptor degeneration in mice. J Neurochem. 2012; 125(1):111-24. DOI: 10.1111/jnc.12116. View

Olchawa M, Krzysztynska-Kuleta O, Mokrzynski K, Sarna P, Sarna T . Quercetin protects ARPE-19 cells against photic stress mediated by the products of rhodopsin photobleaching. Photochem Photobiol Sci. 2020; 19(8):1022-1034. DOI: 10.1039/d0pp00165a. View

Marie M, Bigot K, Angebault C, Barrau C, Gondouin P, Pagan D . Light action spectrum on oxidative stress and mitochondrial damage in A2E-loaded retinal pigment epithelium cells. Cell Death Dis. 2018; 9(3):287. PMC: 5833722. DOI: 10.1038/s41419-018-0331-5. View

Antemie R, Samoila O, Clichici S . Blue Light-Ocular and Systemic Damaging Effects: A Narrative Review. Int J Mol Sci. 2023; 24(6). PMC: 10052719. DOI: 10.3390/ijms24065998. View

Alaimo A, Linares G, Bujjamer J, Gorojod R, Porte Alcon S, Martinez J . Toxicity of blue led light and A2E is associated to mitochondrial dynamics impairment in ARPE-19 cells: implications for age-related macular degeneration. Arch Toxicol. 2019; 93(5):1401-1415. DOI: 10.1007/s00204-019-02409-6. View

Li Y, Zhang P, Huang C, Wang W . Dual effect of blue light on Fusariumsolani clinical corneal isolates in vitro. Lasers Med Sci. 2020; 35(6):1299-1305. DOI: 10.1007/s10103-019-02911-4. View

Song D, Song J, Wang C, Li Y, Dunaief J . Berberine protects against light-induced photoreceptor degeneration in the mouse retina. Exp Eye Res. 2015; 145:1-9. PMC: 4841753. DOI: 10.1016/j.exer.2015.10.005. View

Bian M, Du X, Cui J, Wang P, Wang W, Zhu W . Celastrol protects mouse retinas from bright light-induced degeneration through inhibition of oxidative stress and inflammation. J Neuroinflammation. 2016; 13:50. PMC: 4769581. DOI: 10.1186/s12974-016-0516-8. View

10.

Napolitano P, Filippelli M, Davinelli S, Bartollino S, DellOmo R, Costagliola C . Influence of gut microbiota on eye diseases: an overview. Ann Med. 2021; 53(1):750-761. PMC: 8168766. DOI: 10.1080/07853890.2021.1925150. View

11.

Hsu W, Sangkhathat C, Lu M, Lin W, Liu H, Lin Y . Polysaccharide Attenuates Blue Light-Induced Injury in Retinal Cells and In Vivo in . Antioxidants (Basel). 2024; 13(5). PMC: 11118839. DOI: 10.3390/antiox13050603. View

12.

Feng J, Dong X, Yu H, Shen W, Lv X, Wang R . Cynaroside protects the blue light-induced retinal degeneration through alleviating apoptosis and inducing autophagy in vitro and in vivo. Phytomedicine. 2021; 88:153604. DOI: 10.1016/j.phymed.2021.153604. View

13.

Choi W, Lee J, Cui L, Li Y, Li Z, Choi J . Therapeutic Efficacy of Topically Applied Antioxidant Medicinal Plant Extracts in a Mouse Model of Experimental Dry Eye. Oxid Med Cell Longev. 2016; 2016:4727415. PMC: 4899589. DOI: 10.1155/2016/4727415. View

14.

Ouyang X, Yang J, Hong Z, Wu Y, Xie Y, Wang G . Mechanisms of blue light-induced eye hazard and protective measures: a review. Biomed Pharmacother. 2020; 130:110577. DOI: 10.1016/j.biopha.2020.110577. View

15.

Conti F, Lazzara F, Romano G, Platania C, Drago F, Bucolo C . Caffeine Protects Against Retinal Inflammation. Front Pharmacol. 2022; 12:824885. PMC: 8773454. DOI: 10.3389/fphar.2021.824885. View

16.

van Norren D, Vos J . Light damage to the retina: an historical approach. Eye (Lond). 2015; 30(2):169-72. PMC: 4763118. DOI: 10.1038/eye.2015.218. View

17.

Ouyang W, Wang S, Yan D, Wu J, Zhang Y, Li W . The cGAS-STING pathway-dependent sensing of mitochondrial DNA mediates ocular surface inflammation. Signal Transduct Target Ther. 2023; 8(1):371. PMC: 10514335. DOI: 10.1038/s41392-023-01624-z. View

18.

Hazim R, Volland S, Yen A, Burgess B, Williams D . Rapid differentiation of the human RPE cell line, ARPE-19, induced by nicotinamide. Exp Eye Res. 2018; 179:18-24. PMC: 6360117. DOI: 10.1016/j.exer.2018.10.009. View

19.

Davies S, Elliott M, Floor E, Truscott T, Zareba M, Sarna T . Photocytotoxicity of lipofuscin in human retinal pigment epithelial cells. Free Radic Biol Med. 2001; 31(2):256-65. DOI: 10.1016/s0891-5849(01)00582-2. View

20.

Nguyen Ngo Le M, Wen Y, Ho Y, Kapupara K, Tsai R . Therapeutic Effects of Puerarin Against Anterior Ischemic Optic Neuropathy Through Antiapoptotic and Anti-Inflammatory Actions. Invest Ophthalmol Vis Sci. 2019; 60(10):3481-3491. DOI: 10.1167/iovs.19-27129. View